Vekovia · Bilberry

Akkermansia, paired with the European forest berry the research keeps pointing to.

What it is

A daily capsule that pairs three things — plus one permitted nutrient:

• Pasteurised Akkermansia muciniphila — the strain authorised by the EU as a Novel Food in 2022, and the form studied in the original human proof-of-concept trial.
• Freeze-dried European bilberries (Vaccinium myrtillus) — the wild northern berry with two to four times the anthocyanin content of cultivated blueberries.
• A standardised bilberry polyphenol extract — for a consistent polyphenol dose.
• Chromium, which contributes to the maintenance of normal blood glucose levels.

We pair them because the science links them — not because berries sound nice on a label.

The science, in brief

Akkermansia muciniphila lives in the mucin layer of the gut and is one of the most-studied bacteria in metabolic research. In a 2019 human trial in Nature Medicine, daily supplementation with the pasteurised form over three months was safe and associated with favourable metabolic markers in overweight, insulin-resistant adults (Depommier et al., 2019); a 2025 trial in Cell Metabolism extended this into type 2 diabetes (Zhang et al., 2025). Researchers also identified a protein the bacterium secretes — P9 — that triggers GLP-1 release (Yoon et al., 2021). Bilberry's polyphenols sit alongside this: berry polyphenols of this class shift the microbiota toward Akkermansia and have been studied with insulin sensitivity (Anhê et al., 2015; Lee et al., 2018).

Read the full picture in the science hub.

How to take it

One capsule daily with water. Not suitable for children under 12, pregnant or breastfeeding women. Do not exceed the recommended daily dose. A food supplement is not a substitute for a varied, balanced diet.